Dan Skovronsky is the chief scientific officer at Eli Lilly and Company and serves as Lilly’s executive vice president of science and technology. He is also president of Lilly Research Laboratories, president of Lilly Immunology, and has responsibility for global business development. Skovronsky joined Lilly in 2010 when the company acquired Avid Radiopharmaceuticals, Inc., where he had been CEO since founding the company in 2004. At Lilly, he has held various leadership roles, including chief medical officer; vice president, tailored therapeutics; vice president, diabetes research; and senior vice president, clinical and product development. (Eli Lilly and Company is a 2025 Festival Underwriter)